MTOR and breast cancer: The comparison of energy-balance regimens, such as CR, and pharmacological interventions with well-established mTOR inhibitors has revealed that rapamycin conspicuously mimics CR in its ability to decrease the mammary tumor burden in obese animals [4-6].